These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9464330)

  • 1. [Prognostic effect of PyNPase (pyrimidine nucleoside phosphorylase) activity in breast cancer].
    Nishimura R; Nagao K; Miyayama H; Matsuda M; Baba K; Matsuoka Y; Yamashita H; Fukuda M; Higuchi A; Masuyama S; Uchino S; Matsumoto H
    Gan To Kagaku Ryoho; 1998 Jan; 25(1):59-66. PubMed ID: 9464330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical significance of pyrimidine nucleoside phosphorylase (PyNPase) in breast cancer].
    Seo S; Miki A; Iwaisako K; Kamo N; Inomoto T; Kitai T; Ukikusa M
    Gan To Kagaku Ryoho; 2006 Nov; 33(11):1579-82. PubMed ID: 17108722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of pyrimidine nucleoside phosphorylase and dihydropyrimidine dehydrogenase levels to predict postoperative recurrence in primary breast cancer].
    Tamesa M; Yamamoto S; Maeda N; Nagashima Y; Oka M
    Gan To Kagaku Ryoho; 2008 Mar; 35(3):431-6. PubMed ID: 18347391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of tissue PyNPase, TS, and DPD activities in breast cancer].
    Kosaka A; Mori K; Shikata A
    Gan To Kagaku Ryoho; 2002 Aug; 29(8):1395-401. PubMed ID: 12214467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation between pyrimidine nucleoside phosphorylase (PyNPase) and clinicopathological factors in patients with gastric cancer].
    Onoyama H; Urakawa T; Azumi Y; Hashimoto Y; Sugihara S; Saitoh Y
    Gan To Kagaku Ryoho; 2000 Jul; 27(7):1015-20. PubMed ID: 10925687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymidine kinase and thymidylate synthase in advanced breast cancer: response to tamoxifen and chemotherapy.
    Foekens JA; Romain S; Look MP; Martin PM; Klijn JG
    Cancer Res; 2001 Feb; 61(4):1421-5. PubMed ID: 11245445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratumoral pyrimidine nucleoside phosphorylase (PyNPase) activity predicts a selective effect of adjuvant 5'-deoxy-5-fluorouridine (5'DFUR) on breast cancer.
    Hata Y; Takahashi H; Sasaki F; Ogita M; Uchino J; Yoshimoto M; Akasaka Y; Nakanishi Y; Sawada Y
    Breast Cancer; 2000 Jan; 7(1):37-41. PubMed ID: 11029769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive implications of nucleoside metabolizing enzymes in premenopausal women with node-positive primary breast cancer who were randomly assigned to receive tamoxifen alone or tamoxifen plus tegafur-uracil as adjuvant therapy.
    Toi M; Ikeda T; Akiyama F; Kurosumi M; Tsuda H; Sakamoto G; Abe O
    Int J Oncol; 2007 Oct; 31(4):899-906. PubMed ID: 17786323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of pyrimidine nucleoside phosphorylase mRNA plays an important role in the prognosis of patients with oesophageal cancer.
    Yamagata M; Mori M; Mimori K; Mafune KI; Tanaka Y; Ueo H; Akiyoshi T
    Br J Cancer; 1999 Feb; 79(3-4):565-9. PubMed ID: 10027331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
    Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P
    Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymidylate synthase levels as a therapeutic and prognostic predictor in breast cancer.
    Nishimura R; Nagao K; Miyayama H; Matsuda M; Baba K; Matsuoka Y; Yamashita H; Fukuda M; Higuchi A; Satoh A; Mizumoto T; Hamamoto R
    Anticancer Res; 1999; 19(6C):5621-6. PubMed ID: 10697629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue levels of pyrimidine nucleoside phosphorylase activity in human and rodent bladder cancer and normal bladder tissue.
    Fujimoto K; Matsumura Y; Tani Y; Ozono S; Hirao Y; Okajima E
    Int J Urol; 2007 Aug; 14(8):754-9. PubMed ID: 17681069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Distributions of pyrimidine nucleoside phosphorylase (PyNPase) in tissues of benign and malignant mammary diseases--immunohistochemical observations].
    Fukada D; Saji S; Kawaguchi Y; Nagata M; Shimokawa K; Furuta T
    Gan To Kagaku Ryoho; 1996 May; 23(6):703-6. PubMed ID: 8645021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.
    Gasparini G; Toi M; Miceli R; Vermeulen PB; Dittadi R; Biganzoli E; Morabito A; Fanelli M; Gatti C; Suzuki H; Tominaga T; Dirix LY; Gion M
    Cancer J Sci Am; 1999; 5(2):101-11. PubMed ID: 10198732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
    Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
    Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of response to neoadjuvant chemoendocrine therapy in primary breast carcinomas.
    Makris A; Powles TJ; Dowsett M; Osborne CK; Trott PA; Fernando IN; Ashley SE; Ormerod MG; Titley JC; Gregory RK; Allred DC
    Clin Cancer Res; 1997 Apr; 3(4):593-600. PubMed ID: 9815725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of pyrimidine nucleoside phosphorylase (PyNPase) and dihydropyrimidine dehydrogenase (DPD) in advanced gastric cancers].
    Tsukayama S; Hirano M; Murakami N; Uno Y; Nozawa H; Yoshino H; Orta N; Kikkawa H; Masuda S
    Gan To Kagaku Ryoho; 2001 May; 28(5):649-54. PubMed ID: 11383213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinicopathological significance of pyrimidine nucleoside phosphorylase (PyNPase) and dihydropyrimidine dehydrogenase (DPD) in advanced colorectal cancer].
    Otsuka S; Tanabe S; Tsunemitsu Y; Ariki N; Miyoshi K; Inagaki M; Takahashi M; Oosaki T; Fuchimoto S; Yumura M
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1679-81. PubMed ID: 16315907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [PyNPase and DPD expression potentially predict response to 5'-DFUR treatment for node-positive breast cancer patients].
    Akao S; Inoue K
    Gan To Kagaku Ryoho; 2003 Sep; 30(9):1361-4. PubMed ID: 14518422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting].
    Inaji H; Sakai K; Oka T; Ozawa K; Saito Y; Senoo T; Taguchi T; Terasawa T; Nakao K; Mori T; Koyama H; Oshima A
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1423-9. PubMed ID: 17033231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.